Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis

被引:17
作者
Kamikura, Y
Wada, H
Nobori, T
Matsumoto, T
Shiku, H
Ishikura, K
Yamada, N
Nakano, T
Kazahaya, Y
Sawai, T
Matsuda, M
机构
[1] Mie Univ, Sch Med, Dept Lab Med, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie, Japan
[3] Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie, Japan
[4] Iatron Labs Inc, Chiba, Japan
[5] Ogata Inst Med & Chem Res, Tokyo, Japan
关键词
fibrin degradation products by granulocyte elastase; DVT; SF; D-dimer;
D O I
10.1016/j.thromres.2004.07.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma levels of granulocyte-derived elastase (GE-XDP), D-dimer and soluble fibrin (SF) were examined in 53 patients with deep vein thrombosis (DVT) and in 100 healthy volunteers. The mean plasma level of D-dimer was 0.92 +/- 0.81 mug/ml (+/-S.D.) in healthy volunteers and the mean+2 S.D. value (cutoff value for DVT) was 2.53 mug/ml, which was higher than that used in Europe and North America. Plasma levels of GE-XDP, D-dimer and SF were significantly higher in patients with DVT than in healthy volunteers, and diminished after 1 week of treatment with heparin, urokinase or tissue type plasminogen activator, though were still higher than those of the control subjects. The sensitivity of GE-XDP, D-dimer and SF for DVT was 81.1%, 75.5% and 79.2%, respectively. GE-XDP levels correlated with those of D-dimer and SF. Our results indicate that GE-XDP is a potentially useful marker for the diagnosis of DVT, suggesting that granulocytes are activated in patients with DVT. In our system, the cutoff value of D-dimer for the diagnosis of DVT is higher than in western countries, probably due to the use of different analytical assays. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 28 条
[1]   A MONOCLONAL-ANTIBODY WITH HIGH-AFFINITY FOR A NEO-ANTIGENIC SITE IN FIBRINOGEN DEGRADED BY POLYMORPHONUCLEAR LEUKOCYTE-DERIVED ELASTASE [J].
BOS, R ;
VANLEUVEN, CJM ;
STOLK, J ;
HIEMSTRA, PS ;
DIJKMAN, JH ;
NIEUWENHUIZEN, W .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (03) :259-267
[2]  
Dempfle CE, 2001, THROMB HAEMOSTASIS, V85, P671
[3]   The evaluation of suspected pulmonary embolism [J].
Fedullo, PF ;
Tapson, VF .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1247-1256
[4]  
JANOFF A, 1985, ANNU REV MED, V36, P207
[5]   A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma [J].
Kohno, I ;
Inuzuka, K ;
Itoh, Y ;
Nakahara, K ;
Eguchi, Y ;
Sugo, T ;
Soe, G ;
Sakata, Y ;
Murayama, H ;
Matsuda, M .
BLOOD, 2000, 95 (05) :1721-1728
[6]  
Levi M, 1999, THROMB HAEMOSTASIS, V82, P695
[7]   ENZYMATIC INACTIVATION OF HUMAN ALPHA-1-PROTEINASE INHIBITOR BY NEUTROPHIL MYELOPEROXIDASE [J].
MATHESON, NR ;
WONG, PS ;
TRAVIS, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 88 (02) :402-409
[8]  
MATSUDA M, CURRENT BASIC CLIN A, V4, P43
[9]  
MINAMIKAWA K, 1994, THROMB HAEMOSTASIS, V71, P192
[10]  
Müller-Berghaus G, 1999, THROMB HAEMOSTASIS, V82, P706